Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers

US Patent 11021424 · Granted Jun 1, 2021

Estimated economic value: $25,630,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for detecting viral nucleic acids2025
Mitochondrial therapeutic agents2025
DNA-affibody-drug nanoparticles for inhibiting the metastasis of cancer cells ov2025
Ribosome-mediated incorporation of peptides and peptidomimetics2025
Engineered bacterial ribosome compositions and methods2024
Methods of rational nicotine hapten design and uses thereof2023
Therapeutic compounds2023
Ribosome-mediated incorporation of peptides and peptidomimetics2022
Substituted pyrimidine compounds as multifunctional radical quenchers and their 2022
Methods of rational nicotine hapten design and uses thereof2022
Prodrug and profluorescent compounds for selective mitochondrial imaging and the2021
Substituted phenothiazines as mitochondrial agents2021